Pharming Group N.V.PHAR
那斯達克 · USD
16.62
0.00
(0.00%)
收盤 04/06 10:34 (UTC+8)
04/06 10:34 (UTC+8)
Pharming Group N.V.PHAR
16.62
0.00
(0.00%)
財務數據
損益表
- 0.67
- 0.81
- 0.56
- 0.74
- 0.75
- 927.00
- 0.79
- 0.93
- 0.97
- 1065.00
- 21.43
- 21.84
- -31.56
- 33.29
- 1.02
- 123749.35
- -14.65
- 17.86
- 4.36
- 109369.92
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 106,500,000 | 97,287 | 93,221 | 79,094 | 92,700,000 | 74,849 | 74,093 | 55,586 | 81,217 | 66,661 |
營業成本 | 21,100,000 | 7,071 | 8,972 | 8,323 | 12,200,000 | 6,819 | 7,981 | 8,386 | 7,118 | 8,295 |
營業毛利 | 85,400,000 | 90,216 | 84,249 | 70,771 | 80,500,000 | 68,030 | 66,112 | 47,200 | 74,099 | 58,366 |
營業費用 | 83,400,000 | 74,465 | 75,249 | 78,198 | 73,900,000 | 64,699 | 70,145 | 63,857 | 67,121 | 56,458 |
研發費用 | 32,100,000 | 23,384 | 23,695 | 21,142 | 22,300,000 | 20,721 | 21,597 | 18,521 | 11,627 | 20,753 |
推銷及管理費用 | 51,300,000 | 51,081 | 51,554 | 57,056 | 51,600,000 | 43,978 | 48,548 | 45,336 | -30,484 | 36,009 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | -777 | -912 | -345 | 99,633 | -304 |
營業利益 | 2,000,000 | 15,751 | 9,000 | -7,427 | 6,600,000 | 3,331 | -4,033 | -16,657 | 6,978 | 1,908 |
其他收入及費用 | - | - | - | - | - | - | - | - | - | - |
利息費用 | 1,400,000 | 7,946 | 4 | 5,098 | 0 | 2,998 | 1,974 | 1,556 | 1,343 | 1,652 |
稅前純益 | 4,800,000 | 12,758 | 7,079 | -11,788 | 6,700,000 | 1,514 | -60 | -16,624 | -2,031 | 3,307 |
所得稅 | -500,000 | 5,209 | 2,529 | 3,100 | 3,800,000 | 2,548 | 1,158 | -4,176 | 1,092 | -157 |
稅後純益 | 5,300,000 | 7,548 | 4,694 | -14,719 | 2,900,000 | -1,034 | -1,218 | -12,448 | -3,123 | 3,464 |
基本每股稅後盈餘(元) | 0.08 | - | - | -0.22 | 0.04 | -0.02 | - | -0.19 | - | 0.05 |
稀釋每股稅後盈餘(元) | 0.07 | - | - | -0.22 | 0.04 | -0.02 | - | -0.19 | - | 0.05 |
基本平均股數(千股) | 69668.00 | - | - | 66904.00 | 68030.00 | 51700.00 | - | 65515.00 | - | 69280.00 |
稀釋平均股數(千股) | 69668.00 | - | - | 66904.00 | 68030.00 | 51700.00 | - | 65515.00 | - | 69280.00 |
還原基本每股稅後盈餘(元) | 0.08 | - | - | -0.22 | 0.04 | -0.02 | - | -0.19 | - | 0.05 |
還原稀釋每股稅後盈餘(元) | 0.07 | - | - | -0.22 | 0.04 | -0.02 | - | -0.19 | - | 0.05 |
還原基本平均股數(千股) | 69,668 | - | - | 66,904 | 68,030 | 51,700 | - | 65,515 | - | 69,280 |
還原稀釋平均股數(千股) | 69,668 | - | - | 66,904 | 68,030 | 51,700 | - | 65,515 | - | 69,280 |
EBITDA(千元) | 6,203,206 | 23,429 | 9,929 | -3,939 | 6,707,699 | 7,255 | 1,621 | -9,147 | 6,867 | 7,861 |